- Home
- MODV vs DERM Comparison
MODV vs DERM Comparison
Compare MODV & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- DERM
- Stock Information
- Founded
- MODV 1996
- DERM 2014
- Country
- MODV United States
- DERM United States
- Employees
- MODV N/A
- DERM N/A
- Industry
- MODV Transportation Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- DERM Health Care
- Exchange
- MODV Nasdaq
- DERM Nasdaq
- Market Cap
- MODV 81.8M
- DERM 95.0M
- IPO Year
- MODV N/A
- DERM 2021
- Fundamental
- Price
- MODV $5.05
- DERM $5.19
- Analyst Decision
- MODV Buy
- DERM Strong Buy
- Analyst Count
- MODV 5
- DERM 3
- Target Price
- MODV $18.20
- DERM $9.50
- AVG Volume (30 Days)
- MODV 634.6K
- DERM 54.6K
- Earning Date
- MODV 03-04-2025
- DERM 03-20-2025
- Dividend Yield
- MODV N/A
- DERM N/A
- EPS Growth
- MODV N/A
- DERM N/A
- EPS
- MODV N/A
- DERM N/A
- Revenue
- MODV $2,787,619,000.00
- DERM $57,771,000.00
- Revenue This Year
- MODV $3.37
- DERM N/A
- Revenue Next Year
- MODV $2.71
- DERM $36.49
- P/E Ratio
- MODV N/A
- DERM N/A
- Revenue Growth
- MODV 3.16
- DERM N/A
- 52 Week Low
- MODV $3.64
- DERM $2.85
- 52 Week High
- MODV $39.48
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- MODV 38.32
- DERM 60.26
- Support Level
- MODV $5.73
- DERM $4.85
- Resistance Level
- MODV $6.09
- DERM $5.37
- Average True Range (ATR)
- MODV 0.60
- DERM 0.40
- MACD
- MODV 0.35
- DERM 0.02
- Stochastic Oscillator
- MODV 54.23
- DERM 70.49
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.